USPTO TTABVUE. Trademark Trial and Appeal Board Inquiry System

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

v2.5.0

Opposition

Defendant
Name:	Axcentria Pharmaceuticals, LLC
Correspondence:	MARY L. SHAPIRO EVOKE LAW, PC 201 SPEAR STREET, SUITE 1100, #16 SAN FRANCISCO, CA 94105 UNITED STATES iplaw@evoke.law, mary@evoke.law, nicole@evoke.law Phone: 415-398-3141

Serial #:	90880618	Application File	Assignment
Application Status:	ABANDONED - AFTER INTER-PARTES DECISION
Mark:	ELEA

Plaintiff
Name:	Regeneron Pharmaceuticals, Inc.
Correspondence:	PAUL C. LLEWELLYN ARNOLD & PORTER KAYE SCHOLER LLP 250 WEST 55TH STREET NEW YORK, NY 10019 UNITED STATES trademarkdocketing@arnoldporter.com, paul.llewellyn@arnoldporter.com, hannah.grace@arnoldporter.com, amit.kesar@arnoldporter.com Phone: 212-836-7828

Serial #:	77510978	Application File	Assignment	Registration #:	4088223
Application Status:	REGISTERED AND RENEWED
Mark:	EYLEA


Serial #:	85209921	Application File	Assignment	Registration #:	4100104
Application Status:	REGISTERED AND RENEWED
Mark:	EYLEA


Serial #:	85955455	Application File	Assignment	Registration #:	4566649
Application Status:	REGISTERED AND RENEWED
Mark:	EYLEA (AFLIBERCEPT) INJECTION 4U


Serial #:	85327081	Application File	Assignment	Registration #:	4191718
Application Status:	REGISTERED AND RENEWED
Mark:	EYLEA4U


Serial #:	87722615	Application File	Assignment	Registration #:	5524177
Application Status:	REGISTERED
Mark:	EYLEA


Serial #:	90701063	Application File	Assignment
Application Status:	FIFTH EXTENSION - GRANTED
Mark:	EYLEA

Prosecution History
#	Date	History Text	Due Date
9	07/12/2023	TERMINATED
8	07/12/2023	BD DECISION: OPP DISMISSED W/O PREJ
7	07/12/2023	W/DRAW OF APPLICATION W/ CONSENT
6	06/20/2023	SUSPENDED
5	06/20/2023	P MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS
4	03/23/2023	ANSWER
3	03/15/2023	INSTITUTED
2	03/15/2023	NOTICE AND TRIAL DATES SENT; ANSWER DUE:	04/24/2023
1	03/15/2023	FILED AND FEE